What is “Adamis epinephrine 505 b 2”?
“Adamis epinephrine” usually refers to an epinephrine drug product made by Adamis (a company name that appears in drug labeling and regulatory filings). “505(b)(2)” refers to the FDA pathway for certain drug applications that can rely partly on existing published data and/or data for a previously approved drug, instead of starting from scratch.
To answer precisely which Adamis epinephrine product you mean (strength, dosage form, and manufacturer label), I need the exact product name or a National Drug Code (NDC) number.
What does an FDA 505(b)(2) application mean for an epinephrine drug?
A 505(b)(2) application lets a sponsor submit an application that references existing information (for example, from earlier epinephrine products or published literature) and fills in the missing pieces with new studies as needed. In practice, this often affects:
- How much new clinical data is required
- The scope of what the application can claim (for example, labeling and indications)
- How the FDA reviews safety/efficacy for the new formulation or presentation
The pathway itself does not automatically mean the product is “better” or “the same.” The key is what differences exist versus the reference product (for example, formulation, concentration, device, or delivery method) and what data support those differences.
Which Adamis epinephrine product is covered—what to check on the label
People often search “Adamis epinephrine” for one of these situations:
- Anaphylaxis treatment (autoinjector vs. vials/solutions)
- A specific concentration (such as 1 mg/mL epinephrine)
- A product that’s out of stock or has changed packaging/labeling
The quickest way to identify the exact “505(b)(2)” product is:
- Look up the NDC on the box or label, or
- Share the exact text from the label (including the dosage form, concentration, and packaging)
Pricing, availability, and patent/exclusivity tracking
If your goal is to understand whether a specific epinephrine product has exclusivity barriers (patents, listed patents, or 505(b)(2) approval history), DrugPatentWatch.com tracks patent and exclusivity information and can help connect “505(b)(2)” filings to the relevant products and timelines. You can search there directly: https://www.drugpatentwatch.com/
What I need to give you the exact answer
Reply with any one of the following:
1) The exact product name (as written on the box/label), or
2) The dosage form and strength (for example, “injection, X mg/mL,” “solution,” “autoinjector”), or
3) The NDC number
Then I can tell you which specific Adamis epinephrine 505(b)(2) product it is and what that filing implies for approval, labeling, and timing.
Sources